Recommended Topic Related To:

Ilevro

"Nov. 12, 2012 -- iPads and other tablets with backlit screens may allow millions of people with "low vision" to read faster and easier, a new study suggests.

Low vision is an umbrella term for people who still have trouble reading, wa"...

Ilevro

INDICATIONS

ILEVRO™ (nepafenac ophthalmic suspension), 0.3% is indicated for the treatment of pain and inflammation associated with cataract surgery.

DOSAGE AND ADMINISTRATION

Recommended Dosing

One drop of ILEVRO™ (nepafenac ophthalmic suspension), 0.3% should be applied to the affected eye one-time-daily beginning 1 day prior to cataract surgery, continued on the day of surgery and through the first 2 weeks of the postoperative period. An additional drop should be administered 30 to 120 minutes prior to surgery.

Use with Other Topical Ophthalmic Medications

ILEVRO™ (nepafenac ophthalmic suspension), 0.3% may be administered in conjunction with other topical ophthalmic medications such as beta-blockers, carbonic anhydrase inhibitors, alphaagonists, cycloplegics, and mydriatics.

If more than one topical ophthalmic medication is being used, the medicines must be administered at least 5 minutes apart.

HOW SUPPLIED

Dosage Forms And Strengths

Sterile ophthalmic suspension 0.3%

1.7 mL in a 4 mL bottle

Storage And Handling

ILEVRO™ (nepafenac ophthalmic suspension), 0.3% is supplied in a white, oval, low density polyethylene DROP-TAINER® dispenser with a natural low density polyethylene dispensing plug and gray polypropylene cap presented in an overwrap. Tamper evidence is provided with a shrink band around the closure and neck area of the package.

1.7 mL in 4 mL bottle NDC 0065-1750-07

Storage

Store at 2 -25°C (36 - 77°F).

Protect from light.

Alcon Laboratories, Inc. Fort Worth, Texas 76134 USA. Revised: December 2012

Last reviewed on RxList: 1/4/2013
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


WebMD Daily

Get breaking medical news.